Selling And Administration Expenses 更改
AbbVie USD 3.61B 273M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Ardelyx USD 32.66M 5.48M 2023-09
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Celldex Therapeutics USD 8.83M 611K 2023-12
Curis USD 4.76M 512K 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Incyte USD 293.86M 25.97M 2023-12
Life Technologies USD 2.65M 1.07M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Xoma USD 6.37M 591K 2023-09



Xoma 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.